Commission Implementing Regulation (EU) 2019/291 [Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine (OJ L 48, 20.2.2019, p. 17).] extended the approval period of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, fluazifop P and spiroxamine until 31 December 2023.
Recital 4, Regulation (EU) 2023/2592
In forcesince 21 Nov 2023